Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B G Jacob

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Deutsche Medizinische Wochenschrift (1946)|March 6, 1992
[Cholesterol-lowering effects of garlic?]B G Jacob, P Schwandt
Regulatory Peptides|July 30, 1990
Insulin inhibits lipolytic activity and degradation of beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P Schwandt
Molecular and Cellular Endocrinology|July 9, 1990
Processing of the lipid-mobilizing peptide beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P Schwandt
Annals of Internal Medicine|May 1, 1990
Lovastatin, pravastatin, and serum lipoprotein(a)B G Jacob, W O Richter, P Schwandt
Lancet (London, England)|September 14, 1991
Interaction between fibre and lovastatinW O Richter, B G Jacob, P Schwandt
Der Internist|February 1, 1986
[Pancreatitis as a diagnostic error in masked perforated duodenal ulcer with formation of a retroperitoneal abscess]B G Jacob, W O Richter, T Sauerbruch
Fortschritte Der Medizin|March 20, 1993
[Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators]B G Jacob, W O Richter, P Schwandt
International Journal of Tissue Reactions|January 1, 1991
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteinsW O Richter, B G Jacob, P Schwandt
Journal of Cardiovascular Pharmacology|September 1, 1993
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemiaB G Jacob, W O Richter, P Schwandt
The Clinical Investigator|November 1, 1993
Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapyB G Jacob, W O Richter, P Schwandt
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Deutsche Medizinische Wochenschrift (1946)|March 6, 1992
[Cholesterol-lowering effects of garlic?]B G Jacob, P Schwandt
Regulatory Peptides|July 30, 1990
Insulin inhibits lipolytic activity and degradation of beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P Schwandt
Molecular and Cellular Endocrinology|July 9, 1990
Processing of the lipid-mobilizing peptide beta-lipotropin in rabbit adipose tissueW O Richter, B G Jacob, P Schwandt
Annals of Internal Medicine|May 1, 1990
Lovastatin, pravastatin, and serum lipoprotein(a)B G Jacob, W O Richter, P Schwandt
Lancet (London, England)|September 14, 1991
Interaction between fibre and lovastatinW O Richter, B G Jacob, P Schwandt
Der Internist|February 1, 1986
[Pancreatitis as a diagnostic error in masked perforated duodenal ulcer with formation of a retroperitoneal abscess]B G Jacob, W O Richter, T Sauerbruch
Fortschritte Der Medizin|March 20, 1993
[Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators]B G Jacob, W O Richter, P Schwandt
International Journal of Tissue Reactions|January 1, 1991
Comparative effects of two HMG-CoA reductase inhibitors (lovastatin and pravastatin) on serum lipids and lipoproteinsW O Richter, B G Jacob, P Schwandt
Journal of Cardiovascular Pharmacology|September 1, 1993
Long-term treatment (2 years) with the HMG CoA reductase inhibitors lovastatin or pravastatin in combination with cholestyramine in patients with severe primary hypercholesterolemiaB G Jacob, W O Richter, P Schwandt
The Clinical Investigator|November 1, 1993
Therapy of severe familial heterozygous hypercholesterolemia by low-density lipoprotein apheresis with immunoadsorption: effects of the addition of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors to therapyB G Jacob, W O Richter, P Schwandt
Pageof 2